Keep Out Of Reach Of Children
Keep out of reach of children
The following Structured Product Label (SPL) was submitted to the FDA by Medinatura for the product Bhi Allergy (NDC 62795-1011). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding keep out of reach of children, indication and usage, warnings, dosage and administration, active ingredients, inactive ingredients, purpose, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Keep out of reach of children
For the temporary relief of minor allergy symptoms: runny nose, watery eyes, skin irritations
If pregnant or breast-feeding, ask a health professional before use. If symptoms persist or worsen, a healthcare professional should be consulted. Do not use if known sensitivity to BHI Allergy or any of its ingredients exists.
At first sign of symptoms: Adults and children 4 years and older:
1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 12 tablets in 24 hours
Standard dosage: Adults and children 4 years and older:
3 tablets per day, taking 1 tablet every 4 to 6 hours.
For children under 4, consult you healthcare provider.
Allow tablets to dissolve completely in the mouth, do not swallow.
Active Ingredients:
Each tablet contains: Antimonium crudum 10X, *Arnica montana, radix 6X, Formicumacidum 8X, Graphites 10X, Histaminum hydrochloricum 8X, 12X, 30X, 200X, *Ignatia amara 6X, *Lappa major 8X, *Ledum palustre 8X, *Lycopodium clavatum 6X, *Pix liquida 10X, Selenium metallicum 12X, *Sulphur 12X, Sulphuricum acidum 30X, *Tellurium metallicum 10X, *Thuja occidentalis 6X 16.7 mg each.
*Natural ingredients
Inactive Ingredients: Lactose, Magnesium stearate
Relieves:
• Runny Nose
• Watery Eyes due to Hayfever
• Mild Skin Rashes & Hives
* Please review the disclaimer below.